Rothstein, Brooke. 2018. “Topical JAK Inhibitor Ruxolitinib for Vitiligo Treatment”. SKIN The Journal of Cutaneous Medicine 2 (December):S110-S111. https://doi.org/10.25251/skin.2.supp.102.